Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial von Home, Philip D, Prof, Pocock, Stuart J, Prof, Beck-Nielsen, Henning, Prof, Curtis, Paula S, PhD, Gomis, Ramon, Prof, Hanefeld, Markolf, Prof, Jones, Nigel P, MA, Komajda, Michel, Prof, McMurray, John JV, Prof

Volltext

Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial von Komajda, Michel, McMurray, John J.V., Beck-Nielsen, Henning, Gomis, Ramon, Hanefeld, Markolf, Pocock, Stuart J., Curtis, Paula S., Jones, Nigel P., Home, Philip D.

Volltext

The effect of 24-week belimumab treatment withdrawal followed by treatment restart in patients with SLE: an open-label, non-randomised 52-week study von Bae, Sang-Cheol, Bass, Damon L, Chu, Myron, Curtis, Paula, Dimelow, Richard, Harvey, Laurence, Ji, Beulah, Kurrasch, Regina, Muzaffar, Saima, Punwaney, Raj, Roth, David A, Song, Yeong-Wook, Xie, Wendy, Zhang, Fengchun

Volltext

Long-term safety and efficacy of belimumab in Japanese patients with SLE: A 7-year open-label continuation study von Tanaka, Yoshiya, Curtis, Paula, DeRose, Kathleen, Kurrasch, Regina, Kinoshita, Kyoko, Tanaka, Rika, Yamazaki, Yumi, Roth, David A

Volltext

Efficacy of belimumab in patients with systemic lupus erythematosus from North East Asia: Results of exploratory subgroup analyses von Zheng, Jie, Gu, Jieruo, Su, Yin, Li, Yang, Li, Xingfu, Xiong, Cui, Cao, Hua, Quasny, Holly, Chu, Myron, Curtis, Paula, DeRose, Kathleen, Kurrasch, Regina, Meizlik, Paige, Roth, David A, Zhang, Fengchun

Volltext

1501 Long-term safety of belimumab among adult patients with systemic lupus erythematosus (SLE): pooled data from three open-label extension studies over 11+ years von Mian, Aneela N, Curtis, Paula, Henning, Christine, Khamashta, Munther, Cervera, Ricard, Wallace, Daniel J, Tektonidou, Maria G, Atsumi, Tatsuya

Volltext

Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH) von Escribano-Subias, Pilar, Bendjenana, Hakim, Curtis, Paula S., Lang, Irene, Noordegraaf, Anton Vonk

Volltext

Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea von Tanaka, Yoshiya, Bae, Sang-Cheol, Bass, Damon, Curtis, Paula, Chu, Myron, DeRose, Kathleen, Ji, Beulah, Kurrasch, Regina, Lowe, Jenny, Meizlik, Paige, Roth, David A

Volltext

Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years von Zhang, Fengchun, Zheng, Jie, Li, Yang, Wang, Guochun, Wang, Mingjun, Su, Yin, Gu, Jieruo, Li, Xingfu, Bass, Damon, Chu, Myron, Curtis, Paula, DeRose, Kathleen, Kurrasch, Regina, Lowe, Jenny, Meizlik, Paige, Roth, David A

Volltext

Cancer and bone fractures in observational follow-up of the RECORD study von Jones, Nigel P., Curtis, Paula S., Home, Philip D.

Volltext

Why Were There No Severe Famines in Fourteenth-Century Japan? Social Change, Resilience, and Climatic Cooling von Itō, Keisuke, Curtis, Paula R

Volltext

Incidence and Prevalence of Unrecognized Myocardial Infarction in People With Diabetes: A substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in... von MacDonald, Michael R, Petrie, Mark C, Home, Philip D, Komajda, Michel, Jones, Nigel P, Beck-Nielsen, Henning, Gomis, Ramon, Hanefeld, Markolf, Pocock, Stuart J, Curtis, Paula S, McMurray, John J.V

Volltext

Review: Tekagami & Kyōgire von Curtis, Paula R.

Volltext

Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes:... von Komajda, Michel, Curtis, Paula, Hanefeld, Markolf, Beck-Nielsen, Henning, Pocock, Stuart J, Zambanini, Andrew, Jones, Nigel P, Gomis, Ramon, Home, Philip D

Volltext

Safety and Efficacy of Belimumab in Patients with Lupus Nephritis: Open-Label Extension of BLISS-LN Study von Furie, Richard, Rovin, Brad H, Houssiau, Frédéric, Contreras, Gabriel, Teng, Y K Onno, Curtis, Paula, Green, Yulia, Okily, Mohamed, Madan, Anuradha, Roth, David A

Volltext

Post Hoc Analyses of Biomarkers Predictive of a Renal Response to Intravenous (IV) Belimumab (BEL) Plus Standard Therapy (ST) in Patients with Lupus Nephritis (LN): SA-PO881 von Rovin, Brad H., Furie, Richard, Malvar, Ana, Aranow, Cynthia, Pego-Reigosa, José M., Zakharova, Elena, Schwarting, Andreas, Jones-Leone, Angela R., Gilbride, Jennifer A., Ji, Beulah, Roth, David A., Curtis, Paula S., Maurik, André van

Volltext

Sample size estimation for non-inferiority trials of time-to-event data von Crisp, Adam, Curtis, Paula

Volltext

FC 034SAFETY AND EFFICACY OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH LUPUS NEPHRITIS: A 6-MONTH OPEN-LABEL EXTENSION von Rovin, Brad, Furie, Richard, Houssiau, Frédéric A, Contreras, Gabriel, Teng, Y K O, Curtis, Paula, Madan, Anuradha, Jones-leone, Angela, Gonzalez-Rivera, Tania, Okily, Mohamed, Roth, David

Volltext

Incidence and Prevalence of Unrecognized Myocardial Infarction in People With Diabetes von MacDonald, Michael R., Petrie, Mark C., Home, Philip D., Komajda, Michel, Jones, Nigel P., Beck-Nielsen, Henning, Gomis, Ramon, Hanefeld, Markolf, Pocock, Stuart J., Curtis, Paula S., McMurray, John J.V.

Volltext

Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in... von MacDonald, Michael R, Petrie, Mark C, Home, Philip D, Komajda, Michel, Jones, Nigel P, Beck-Nielsen, Henning, Gomis, Ramon, Hanefeld, Markolf, Pocock, Stuart J, Curtis, Paula S, McMurray, John JV

Volltext